SCHEMBL8520041

SCHEMBL8520041

CCCCCC1CCc2ccccc2N1Br

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 4/20 0.44
CHRM4 P08173 4/20 0.44
CHRM5 P08912 4/20 0.44
CHRM1 P11229 4/20 0.44
DRD2 P14416 4/20 0.44
CHRM3 P20309 4/20 0.44
DRD4 P21917 4/20 0.44
DRD3 P35462 4/20 0.44
MTNR1A P48039 7/20 0.42
ADRB2 P07550 1/20 0.39
ADRB1 P08588 1/20 0.39
ADRA1D P25100 1/20 0.39
ADRA1A P35348 1/20 0.39
ADRA1B P35368 1/20 0.39
PRKCD Q05655 4/20 0.39
ALDH1A1 P00352 2/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
CYP2D6 P10635 2/20 0.36
POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30395273 0.84 MTNR1A (0.54) CHRM2CHRM4CHRM5CHRM1DRD2
SCHEMBL29058373 0.84 MTNR1A (0.54) CHRM2CHRM4CHRM5CHRM1DRD2
SCHEMBL30395009 0.84 MTNR1A (0.54) CHRM2CHRM4CHRM5CHRM1DRD2
SCHEMBL10816361 0.82 CHRM2 (0.44) CHRM2CHRM4CHRM5CHRM1DRD2
SCHEMBL8553144 0.81 CHRM2 (0.43) CHRM2CHRM4CHRM5CHRM1DRD2
SCHEMBL28240256 0.79 MTNR1A (0.48) CHRM2CHRM4CHRM5CHRM1DRD2
SCHEMBL8556209 0.78 CHRM2 (0.43) CHRM2CHRM4CHRM5CHRM1DRD2
SCHEMBL21081149 0.72 MTNR1A (0.58) CHRM2CHRM4CHRM5CHRM1DRD2
SCHEMBL28323374 0.71 POLB (0.47) CHRM2CHRM4CHRM1CHRM3MEN1
SCHEMBL8520039 0.71 MTNR1A (0.48) CHRM2CHRM4CHRM5CHRM1DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0937045-A1 N-ARYL SUBSTITUTED TETRAHYDROQUINOLINES LIGANDS FOR RETINOID RECEPTORS HAVING AGONIST, ANTAGONIST OR INVERSE AGONIST TYPE ACTIVITY Allergan Sales, Inc. (US) 1999-08-25 EP disclosed
WO-1998019999-A1 N-ARYL SUBSTITUTED TETRAHYDROQUINOLINES LIGANDS FOR RETINOID RECEPTORS HAVING AGONIST, ANTAGONIST OR INVERSE AGONIST TYPE ACTIVITY ALLERGAN SALES, INC. (US) 1998-05-14 WO disclosed